CDH1 and familial pancreatic carcinoma: In support of a similar situation in pancreatic cancer cells, we did not observe an inhibition of the β-catenin-dependent transcriptional response upon knockdown of BCL9L despite of increased binding of β-catenin to E-cadherin.